CPHI vs LDOS · rev $4.1M vs P/E 16, rev $16.66B
China Pharma Holdings Inc (CPHI) versus Leidos Holdings Inc (LDOS) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Leidos Holdings Inc (LDOS) is a information technology services company listed on US.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported LDOS revenue for 2025-01-03 was $16.66B. Net income was $1.25B. Revenue was up 7.9% from 2023-12-29 to 2025-01-03. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
CPHI currently screens at market cap $29.0M. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
Not investment advice. Open the CPHI and LDOS stock pages for the full models.
Not investment advice.